Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
|
Aspirin and Clopidogrel in Stroke/TIA
Henry I. Bussey, Pharm.D., FCCP, FAHA
August 2004
Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004 Jul 24;364(9431):331-7.
Adding low dose aspirin (75mg daily) to clopidogrel in 3,759 high risk patients with a recent stroke or TIA failed to show any benefit when compared to 3,781 patients who received clopidogrel and placebo. Surprisingly, however, life-threatening bleeding was significantly increased with the addition of aspirin: 96 of 3,759 (3%) vs. 49 of 3,781 (1%), Similarly, major bleeding was increased 73 of 3,759 (2%) vs. 22 of 3,781 (1%). The higher rate of both categories of bleeding was statistically significant (p < 0.0001) in both cases. This combination has been shown to be beneficial in other indications and is being studied in stroke prevention. Approximately one-half of these patients had ischemia due to small vessel occlusion, one-third were due to large vessel atherosclerosis, and less than 5% were due to cardioembolic events. Other studies are evaluating this combination in primary prophylaxis of stroke and secondary prophylaxis of different types of stroke.
|
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
New Postings:
Click here to view full list of new postings
|